- Home
- SCLX vs TYGO Comparison
SCLX vs TYGO Comparison
Compare SCLX & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- TYGO
- Stock Information
- Founded
- SCLX 2011
- TYGO 2007
- Country
- SCLX United States
- TYGO United States
- Employees
- SCLX N/A
- TYGO N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- TYGO Semiconductors
- Sector
- SCLX Health Care
- TYGO Technology
- Exchange
- SCLX Nasdaq
- TYGO Nasdaq
- Market Cap
- SCLX 51.3M
- TYGO 45.8M
- IPO Year
- SCLX N/A
- TYGO N/A
- Fundamental
- Price
- SCLX $4.06
- TYGO $0.77
- Analyst Decision
- SCLX Strong Buy
- TYGO Buy
- Analyst Count
- SCLX 4
- TYGO 3
- Target Price
- SCLX $396.67
- TYGO $3.00
- AVG Volume (30 Days)
- SCLX 103.2K
- TYGO 25.0K
- Earning Date
- SCLX 05-12-2025
- TYGO 05-06-2025
- Dividend Yield
- SCLX N/A
- TYGO N/A
- EPS Growth
- SCLX N/A
- TYGO N/A
- EPS
- SCLX N/A
- TYGO N/A
- Revenue
- SCLX $56,590,000.00
- TYGO $54,014,000.00
- Revenue This Year
- SCLX $115.30
- TYGO $61.65
- Revenue Next Year
- SCLX $73.33
- TYGO $28.03
- P/E Ratio
- SCLX N/A
- TYGO N/A
- Revenue Growth
- SCLX 21.07
- TYGO N/A
- 52 Week Low
- SCLX $5.80
- TYGO $0.58
- 52 Week High
- SCLX $80.50
- TYGO $1.85
- Technical
- Relative Strength Index (RSI)
- SCLX 24.27
- TYGO 44.44
- Support Level
- SCLX $3.60
- TYGO $0.70
- Resistance Level
- SCLX $7.64
- TYGO $0.85
- Average True Range (ATR)
- SCLX 1.21
- TYGO 0.10
- MACD
- SCLX -0.37
- TYGO 0.01
- Stochastic Oscillator
- SCLX 6.67
- TYGO 67.14
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.